Invention Grant
- Patent Title: Indanyloxydihydrobenzofuranylacetic acids
-
Application No.: US15097857Application Date: 2016-04-13
-
Publication No.: US09597310B2Publication Date: 2017-03-21
- Inventor: Matthias Eckhardt , Sara Frattini , Elke Langkopf , Holger Wagner
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; David L. Kershner
- Priority: EP12196011 20121207
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/497 ; C07D417/12 ; C07D401/12 ; A61K31/343 ; A61K31/085 ; A61K31/192 ; A61K31/34 ; A61K31/09 ; A61K31/4025 ; A61K31/41 ; A61K31/4155 ; A61K31/4178 ; A61K31/443 ; A61K31/5377 ; A61K45/06 ; C07D307/80 ; C07D405/12 ; C07D405/14 ; C07D407/12 ; C07D413/12 ; A61K31/351 ; A61K31/357 ; A61K31/36 ; A61K31/404 ; A61K31/416 ; A61K31/4196 ; A61K31/422 ; A61K31/4245 ; A61K31/427 ; A61K31/4709
Abstract:
The present invention relates to compounds of general formula I, wherein the groups (Het)Ar and R1 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
Public/Granted literature
- US20160235706A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS Public/Granted day:2016-08-18
Information query
IPC分类:
